Clinical Trial Update: Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

View source ↗

Summary

This completed observational study evaluated the safety of Levemir (insulin detemir) in people with type 1 and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED